![12.05.23.Pipeline Update 12.05.23.Pipeline Update](https://aiviva.com/wp-content/uploads/2023/12/12.05.23.Pipeline-Update.jpg)
Development Candidates
![cr=w_365,h_365 cr=w_365,h_365](https://aiviva.com/wp-content/uploads/bb-plugin/cache/crw_365h_365-circle-09763c31f65e833658d145d3c9776f24-e83t91m4i6wv.webp)
AIV001
Prolonged-Release Formulation For Intradermal Treatment
![rs=w_365,h_365,cg_true rs=w_365,h_365,cg_true](https://aiviva.com/wp-content/uploads/bb-plugin/cache/rsw_365h_365cg_true-circle-8d0442a38573b5a13b60ae6eff2f2c00-8o307qk96sch.webp)
AIV007
Gel Formulation Designed for Less Frequent Injection Regimen
![rs=w_365,h_365,cg_true (1) rs=w_365,h_365,cg_true (1)](https://aiviva.com/wp-content/uploads/bb-plugin/cache/rsw_365h_365cg_true-1-circle-2db9e0cf2e86a820632391f5c286e28d-pk4bwdi2yvqm.webp)
JEL™ Technology
Proprietary technology that is customizable to optimize drug release and therapeutic effect